Is IMTXW or DIVO a better dividend investment in 2026?

IMTXW currently yields 333333.33% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: IMTXW offers higher current income.

What is the dividend yield difference between IMTXW and DIVO?

IMTXW has a forward dividend yield of 333333.33% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 333326.84 percentage points.

Home › Compare › IMTXW vs DIVO

IMTXW vs DIVO: Dividend Comparison 2026

IMTXW yields 333333.33% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMTXW wins by $8.099219044190773e+31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMTXW

● Live price

333333.33%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.099219044190773e+31M

Annual income

$80,944,421,463,343,720,000,000,000,000,000,000,000.00

Full IMTXW calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — IMTXW vs DIVO

📍 IMTXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMTXW	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMTXW + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMTXW pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMTXW

Annual income on $10K today (after 15% tax)

$28,333,333.33/yr

After 10yr DRIP, annual income (after tax)

$68,802,758,243,842,160,000,000,000,000,000,000,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, IMTXW beats the other by $68,802,758,243,842,160,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMTXW + DIVO for your $10,000?

IMTXW: 50%DIVO: 50%

100% DIVO50/50100% IMTXW

Portfolio after 10yr

$4.0496095220953863e+31M

Annual income

$40,472,210,731,671,860,000,000,000,000,000,000,000.00/yr

Blended yield

99.94%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMTXW buys

DIVO buys

No recent congressional trades found for IMTXW or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMTXWDIVO

Forward yield	333333.33% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$8.099219044190773e+31M	$30.7K ✓
Annual income after 10y	$80,944,421,463,343,720,000,000,000,000,000,000,000.00 ✓	$981.68
Total dividends collected	$8.098906375781879e+31M	$8.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IMTXW vs DIVO ($10,000, DRIP)

Year	IMTXW Portfolio	IMTXW Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$33,344,033	$33,333,333.33	$11,349	$649.42	+$33.33M → IMTXW
2	$103,911,171,366	$103,875,493,250.26	$12,833	$688.83	+$103911.16M → IMTXW
3	$302,644,656,190,810	$302,533,471,237,448.00	$14,459	$727.90	+$302644656.18M → IMTXW
4	$823,817,797,451,856,400	$823,493,967,669,732,100.00	$16,238	$766.49	+$823817797451.84M → IMTXW
5	$2,095,836,995,961,804,000,000	$2,094,955,510,918,530,000,000.00	$18,179	$804.47	+$2095836995961804.00M → IMTXW
6	$4,983,251,920,823,462,000,000,000	$4,981,009,375,237,783,000,000,000.00	$20,293	$841.71	+$4983251920823461888.00M → IMTXW
7	$11,073,835,968,753,321,000,000,000,000	$11,068,503,889,198,040,000,000,000,000.00	$22,591	$878.14	+$1.1073835968753322e+22M → IMTXW
8	$22,999,277,308,531,336,000,000,000,000,000	$22,987,428,304,044,770,000,000,000,000,000.00	$25,087	$913.65	+$2.2999277308531335e+25M → IMTXW
9	$44,643,905,199,991,210,000,000,000,000,000,000	$44,619,295,973,271,085,000,000,000,000,000,000.00	$27,791	$948.18	+$4.464390519999121e+28M → IMTXW
10	$80,992,190,441,907,720,000,000,000,000,000,000,000	$80,944,421,463,343,720,000,000,000,000,000,000,000.00	$30,718	$981.68	+$8.099219044190773e+31M → IMTXW

IMTXW vs DIVO: Complete Analysis 2026

IMTXW — Stock

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

Full IMTXW Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this IMTXW vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMTXW vs SCHD IMTXW vs JEPI IMTXW vs O IMTXW vs KO IMTXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.